NanoViricides, Inc. (NNVC) Insider Trading Activity

AMEX$1.29-0.09 (-6.52%)
Market Cap
$35.22M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
676 of 847
Rank in Industry
389 of 490

NNVC Insider Trading Activity

NNVC Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About NanoViricides, Inc.

NanoViricides, Inc. operates as a nano-biopharmaceutical entity, specializing in the research, development, and market introduction of pharmaceutical solutions to combat viral infections. The company's robust product pipeline includes a Human Coronavirus Program, specifically engineered to tackle both COVID-19 and various seasonal coronaviruses. For herpes-related conditions, it offers HerpeCide in multiple forms: dermal topical and eye drops to treat ailments such as shingles, postherpetic neuralgia (PHN), chickenpox, recurrent herpes …

Insider Activity of NanoViricides, Inc.

Over the last 12 months, insiders at NanoViricides, Inc. have bought $0 and sold $0 worth of NanoViricides, Inc. stock.

On average, over the past 5 years, insiders at NanoViricides, Inc. have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 25,000 shares for transaction amount of $30,000 was made by BONIUK MILTON (director) on 2015‑11‑11.

List of Insider Buy and Sell Transactions, NanoViricides, Inc.

2015-11-11PurchaseBONIUK MILTONdirector
25,000
0.0431%
$1.20
$30,000
+33.88%
2015-10-22PurchaseBONIUK MILTONdirector
14,640
0.0254%
$1.30
$19,032
+24.62%
2015-10-21PurchaseBONIUK MILTONdirector
5,202
0.009%
$1.30
$6,763
+24.62%
2015-10-19PurchaseBONIUK MILTONdirector
2,958
0.0051%
$1.30
$3,845
+22.73%
2015-10-15PurchaseBONIUK MILTONdirector
2,200
0.0037%
$1.30
$2,860
+20.00%
2015-09-11PurchaseBONIUK MILTONdirector
50,000
0.0873%
$1.02
$51,000
+53.92%
2015-08-26PurchaseBONIUK MILTONdirector
50,000
0.0921%
$1.05
$52,500
+55.65%
2015-08-21PurchaseBONIUK MILTONdirector
29,853
0.053%
$1.25
$37,316
+26.02%
2015-08-20PurchaseBONIUK MILTONdirector
2,662
0.0046%
$1.25
$3,328
+24.00%
2015-08-19PurchaseBONIUK MILTONdirector
300
0.0005%
$1.25
$375
+20.16%
2015-08-18PurchaseBONIUK MILTONdirector
2,547
0.0043%
$1.25
$3,184
+20.16%
2015-08-17PurchaseBONIUK MILTONdirector
5,244
0.0092%
$1.25
$6,555
+24.00%
2015-08-14PurchaseBONIUK MILTONdirector
8,594
0.0148%
$1.25
$10,743
+20.47%
2015-08-13PurchaseBONIUK MILTONdirector
800
0.0013%
$1.25
$1,000
+14.18%
2015-07-08PurchaseBONIUK MILTONdirector
50,000
0.092%
$1.58
$79,000
-6.00%
2015-06-22PurchaseBONIUK MILTONdirector
43,472
0.074%
$1.90
$82,597
-27.69%
2015-06-19PurchaseBONIUK MILTONdirector
6,528
0.0113%
$1.90
$12,403
-27.08%
2015-06-16PurchaseBONIUK MILTONdirector
42,247
0.0738%
$1.99
$84,072
-29.15%
2015-06-15PurchaseBONIUK MILTONdirector
7,753
0.0135%
$2.00
$15,506
-29.50%
2015-05-20PurchaseBONIUK MILTONdirector
25,000
0.0431%
$1.60
$40,000
-12.96%
Total: 207

Insider Historical Profitability

1.91%
Seymour EugeneChief Executive Officer
6025000
23.6043%
$8.31M10
+75.74%
Diwan AnilPresident
2074918
8.129%
$2.86M975
+24.68%
BONIUK MILTONdirector
150000
0.5877%
$207,000.00350
<0.0001%
VYAS MEETAChief Financial Officer
147021
0.576%
$202,888.9810
<0.0001%

Historical Insider Profitability vs. Competitors

$2,542,362
111
11.81%
$37.51M
$156,891,025
80
-24.91%
$37.42M
$84,911,583
59
17.82%
$39.06M
$693,326
47
-16.24%
$39.76M
NanoViricides, Inc.
(NNVC)
$6,204,522
45
1.91%
$35.22M

NNVC Institutional Investors: Active Positions

Increased Positions23+76.67%2M+120.54%
Decreased Positions6-20%46,044-3.22%
New Positions11New2MNew
Sold Out Positions3Sold Out3,336Sold Out
Total Postitions47+56.67%3M+117.32%

NNVC Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$733.002.75%605,583+95,167+18.64%2025-09-30
Renaissance Technologies Llc$255.000.96%210,500+99,100+88.96%2025-09-30
Geode Capital Management, Llc$193.000.73%159,427+1,433+0.91%2025-09-30
Blackrock, Inc.$192.000.72%158,75200%2025-09-30
Susquehanna International Group, Llp$63.000.24%52,217+52,217New2025-09-30
State Street Corp$51.000.19%41,90600%2025-09-30
Bridgeway Capital Management, Llc$44.000.16%36,039-8,000-18.17%2025-09-30
Ubs Group Ag$32.000.12%26,728-90,440-77.19%2025-09-30
Northern Trust Corp$29.000.11%24,25600%2025-09-30
Moss Adams Wealth Advisors Llc$21.000.08%17,000+2,000+13.33%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.